The making of indigenous vascular prosthesis

Simple item page
dc.contributor.authorMadathipat, Unnikrishnan
dc.contributor.authorSidharth, Viswanathan
dc.contributor.authorK., Balasubramaniam
dc.contributor.authorCV, Muraleedharan
dc.contributor.authorArthur Vijayan, Lal
dc.contributor.authorPV, Mohanan
dc.contributor.authorMeera, Mohanty
dc.contributor.authorTirur Raman, Kapilamoorthy
dc.date.accessioned2016-12-05T03:02:08Z
dc.date.available2016-12-05T03:02:08Z
dc.date.issued2016-06
dc.description.abstractBackground & objectives: Vascular illnesses are on the rise in India, due to increase in lifestyle diseases and demographic transition, requiring intervention to save life, organ or limbs using vascular prosthesis. The aim of this study was to develop indigenous large diameter vascular graft for treatment of patients with vascular pathologies. Methods: The South India Textile Research Association, at Coimbatore, Tamil Nadu, India, developed seamless woven polyester (Polyethylene terephthalate) graft at its research wing. Further characterization and testing followed by clinical trials were conducted at Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India. Fifteen in vivo experiments were carried out in 1992-1994 in pigs as animal model. Controlled (phase I) clinical trial in ten patients was performed along with control graft. Thereafter, phase II trial involved 22 patients who underwent multi-centre clinical trial in four centres across India. Results: Laboratory testing showed that polyester graft was non-toxic, non-leeching and nonhaemolytic with preserved long-term quality, further confirming in pigs by implanting in thoracic aorta, comparable to control Dacron grafts. Perigraft incorporation and smooth neointima formation which are prime features of excellent healing characteristics, were noted at explantation at planned intervals. Subsequently in the phase I and II clinical trials, all patients had excellent recovery without mortality or device-related adverse events. Patients receiving the test graft were followed up for 10 and 5 years, respectively. Serial clinical, duplex scans and CT angiograms performed periodically confirmed excellent graft performance. Interpretation & conclusions: Indigenously developed Chitra vascular graft was comparable to commercially available Dacron graft, ready for clinical use at affordable cost to patients as against costly imported grafts.en_US
dc.identifier.urihttp://dx.doi.org/10.4103/0971-5916.192059
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/2855
dc.publisherTHE INDIAN JOURNAL OF MEDICAL RESEARCHen_US
dc.subjectAortic aneurysm - coarctation of aorta - surgical repair - vascular diseases - vascular prosthesisen_US
dc.titleThe making of indigenous vascular prosthesisen_US
dc.typeArticleen_US
Files
Collections
Journal Articles